CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project explores the Neurokinin 2 Receptor as a target for obesity treatment. By understanding its role in appetite regulation and energy homeostasis, the research aims to develop therapies that reduce appetite without adverse effects, potentially improving treatment for metabolic diseases.
Metabolic diseases such as obesity and diabetes rank among the primary causes of mortality worldwide.
While new incretin-based drugs have made major inroads into the treatment of these diseases, issues with tolerance (including nausea, vomiting, diarrhea; and gastroparesis leading to delayed gastric emptying) threaten to limit the potential long-term compliance and impact of these medications.
Thus, it is highly relevant to identify therapeutic targets that reduce appetite without activating ave…
KOBENHAVNS UNIVERSITET
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
United States, Ann Arbor
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
